|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Cash – restricted | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Short-term prepaid insurance | ||||||||||
| Prepaid income taxes | ||||||||||
| Total current assets | ||||||||||
| Long-term prepaid insurance | ||||||||||
| Cash and investments held in Trust Account | ||||||||||
| Total Assets | ||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||
| Current liabilities | ||||||||||
| Accrued expenses | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Income taxes payable | ||||||||||
| Excise taxes payable | ||||||||||
| Promissory note – related party | ||||||||||
| Due to Sponsor | ||||||||||
| Sponsor | ||||||||||
| Total due to Sponsor | ||||||||||
| Total current liabilities | ||||||||||
| Total Liabilities | ||||||||||
| Common stock subject to possible redemption, 759,139 and 1,490,880 shares at redemption value of $11.04 and 10.72 per share as of June 30, 2026 and September 30, 2025, respectively | ||||||||||
| Stockholders’ Deficit | ||||||||||
| Common stock, $0.0001 par value, 100,000,000 shares authorized, 4,249,090 shares issued and outstanding as of June 30, 2026 and September 30, 2025 | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated Deficit | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
